DURHAM, N.C.--(BUSINESS WIRE)--MED-EL USA announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for MED-EL cochlear implants for children seven months and older with bilateral sensorineural hearing loss (SNHL). This makes MED-EL's cochlear implant system the only FDA-approved option for infants this young, offering the potential for earlier access to sound and speech development. "Giving children access to sound as early as possible can make a world of differen ...